Dexcom Inc DXCM

NASDAQ US Health Care

$83.45 ▲ +11.95% (+$8.91)

Index member: S&P 500

⬆️ Above Yest. High

Open $79.88

Prev Close $74.54

Day Range $79.50 – $84.70

52W Range $54.11 – $87.00

Market Cap $28.76B

P/E (TTM) 34.61

Beta 1.41

EPS (TTM) $2.31

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2005-04-14
Shares Out.	385,870,000
Website	dexcom.com/ ↗
Phone	13026365400
Employees	11,100
Revenue	$1.19B
Gross Profit	$750.3M
Net Income	$199.5M
Free Cash Flow	$1.43B
Total Assets	$6.63B
Total Liabilities	$3.68B
Equity	$2.96B

About Dexcom Inc

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.

Dexcom Inc is a publicly traded company under the ticker symbol DXCM on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.